• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲胎蛋白的岩藻糖基化指数及其在肝细胞癌早期诊断中的应用价值

The fucosylation index of alpha-fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma.

作者信息

Aoyagi Y, Suzuki Y, Isemura M, Nomoto M, Sekine C, Igarashi K, Ichida F

机构信息

Department of Internal Medicine, Niigata University School of Medicine, Japan.

出版信息

Cancer. 1988 Feb 15;61(4):769-74. doi: 10.1002/1097-0142(19880215)61:4<769::aid-cncr2820610422>3.0.co;2-m.

DOI:10.1002/1097-0142(19880215)61:4<769::aid-cncr2820610422>3.0.co;2-m
PMID:2448024
Abstract

The serum concentration and degree of fucosylation (fucosylation index) of alpha-fetoprotein (AFP) were determined in serum samples from 258 patients with hepatocellular carcinoma (HCC) and 114 patients with benign liver diseases. When the serum AFP concentration was below 1000 ng/ml, it could not be used as a measure to distinguish between HCC and benign liver diseases. However, the fucosylation index of AFP proved useful for such a purpose. The sensitivity of the analysis using the fucosylation index in total patients with HCC was 69%; the specificity was 96% in benign liver diseases, and the accuracy of this test was 77%. When HCC patients who were grouped according to tumor size (5 cm, 3 cm, and 2 cm in diameter) were analyzed, they all had a fucosylation index significantly higher than that in benign liver disease patients. The mean fucosylation index in 28 patients with a serum AFP concentration below 1000 ng/ml and a tumor diameter less than 3 cm was 26 +/- 30%. Corresponding values for 16 patients with an AFP concentration below 400 ng/ml and a tumor size less than 3 cm and for 8 patients with a concentration below 400 ng/ml and a tumor size less than 2 cm were 32 +/- 31% and 27 +/- 27%, respectively. These values were higher, with statistical significance, than those in patients with benign liver diseases. These data indicate that the measurement of the fucosylation index of AFP is useful for the early diagnosis of HCC.

摘要

测定了258例肝细胞癌(HCC)患者和114例良性肝病患者血清样本中甲胎蛋白(AFP)的血清浓度和岩藻糖基化程度(岩藻糖基化指数)。当血清AFP浓度低于1000 ng/ml时,它不能作为区分HCC和良性肝病的指标。然而,AFP的岩藻糖基化指数被证明可用于此目的。使用岩藻糖基化指数对所有HCC患者进行分析的敏感性为69%;在良性肝病中特异性为96%,该检测的准确性为77%。当根据肿瘤大小(直径5 cm、3 cm和2 cm)对HCC患者进行分组分析时,他们的岩藻糖基化指数均显著高于良性肝病患者。28例血清AFP浓度低于1000 ng/ml且肿瘤直径小于3 cm的患者,其平均岩藻糖基化指数为26±30%。16例AFP浓度低于400 ng/ml且肿瘤大小小于3 cm的患者以及8例浓度低于400 ng/ml且肿瘤大小小于2 cm的患者的相应值分别为32±31%和27±27%。这些值均高于良性肝病患者,具有统计学意义。这些数据表明,测定AFP的岩藻糖基化指数对HCC的早期诊断有用。

相似文献

1
The fucosylation index of alpha-fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma.甲胎蛋白的岩藻糖基化指数及其在肝细胞癌早期诊断中的应用价值
Cancer. 1988 Feb 15;61(4):769-74. doi: 10.1002/1097-0142(19880215)61:4<769::aid-cncr2820610422>3.0.co;2-m.
2
The usefulness of simultaneous determinations of glucosaminylation and fucosylation indices of alpha-fetoprotein in the differential diagnosis of neoplastic diseases of the liver.同时测定甲胎蛋白的糖胺基化和岩藻糖基化指数在肝脏肿瘤性疾病鉴别诊断中的应用价值。
Cancer. 1991 May 1;67(9):2390-4. doi: 10.1002/1097-0142(19910501)67:9<2390::aid-cncr2820670928>3.0.co;2-v.
3
Carbohydrate-based measurements on alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma.基于碳水化合物的甲胎蛋白检测在肝细胞癌早期诊断中的应用
Glycoconj J. 1995 Jun;12(3):194-9. doi: 10.1007/BF00731319.
4
The ratio of fucosylation of alpha-fetoprotein in hepatoblastoma.
Cancer. 1989 Jun 1;63(11):2174-6. doi: 10.1002/1097-0142(19890601)63:11<2174::aid-cncr2820631118>3.0.co;2-6.
5
[Clinical significance of transiently elevated serum AFP level in developing hepatocellular carcinoma in HBsAg positive-liver cirrhosis].[HBsAg 阳性肝硬化患者发生肝细胞癌过程中血清甲胎蛋白水平短暂升高的临床意义]
Korean J Gastroenterol. 2004 Apr;43(4):252-9.
6
Plasma fucosyltransferase activity in patients with hepatocellular carcinoma, with special reference to correlation with fucosylated species of alpha-fetoprotein.肝细胞癌患者的血浆岩藻糖基转移酶活性,特别提及与甲胎蛋白岩藻糖基化种类的相关性。
J Hepatol. 2000 Jun;32(6):946-54. doi: 10.1016/s0168-8278(00)80099-9.
7
Differential lectin reactivities of alpha-fetoprotein in hepatocellular carcinoma: diagnostic value when serum alpha-fetoprotein levels are slightly raised.肝细胞癌中甲胎蛋白的凝集素反应差异:血清甲胎蛋白水平轻度升高时的诊断价值
J Gastroenterol Hepatol. 1992 May-Jun;7(3):260-5. doi: 10.1111/j.1440-1746.1992.tb00976.x.
8
Fucosylation index of alpha-fetoprotein, a possible aid in the early recognition of hepatocellular carcinoma in patients with cirrhosis.甲胎蛋白的岩藻糖基化指数,可能有助于早期识别肝硬化患者的肝细胞癌。
Hepatology. 1993 Jan;17(1):50-2.
9
Highly enhanced fucosylation of serum glycoproteins in patients with hepatocellular carcinoma.肝细胞癌患者血清糖蛋白的岩藻糖基化显著增强。
J Gastroenterol Hepatol. 1999 May;14(5):436-45. doi: 10.1046/j.1440-1746.1999.01882.x.
10
Lectin-affinity electrophoresis for the detection of AFP microheterogeneities in patients with hepatocellular carcinoma.用于检测肝细胞癌患者甲胎蛋白微异质性的凝集素亲和电泳
Anticancer Res. 1996 Jan-Feb;16(1):305-9.

引用本文的文献

1
Fucosylation in digestive inflammatory diseases and cancers: From mechanical studies to clinical translation.消化系统炎症性疾病和癌症中的岩藻糖基化:从机制研究到临床转化
Genes Dis. 2025 Feb 22;12(6):101570. doi: 10.1016/j.gendis.2025.101570. eCollection 2025 Nov.
2
Application of Indirect ELISA and PCR Techniques for Detecting of Hepatocellular Carcinoma using Des-gamma Carboxyprothrombin, Alpha-fetoprotein, and Thioredoxin Biomarkers.使用去γ羧基凝血酶原、甲胎蛋白和硫氧还蛋白生物标志物的间接酶联免疫吸附测定法和聚合酶链反应技术在肝细胞癌检测中的应用
Mol Biotechnol. 2025 Feb 25. doi: 10.1007/s12033-025-01401-z.
3
Roles of core fucosylation modification in immune system and diseases.
核心岩藻糖基化修饰在免疫系统及疾病中的作用。
Cell Insight. 2024 Oct 9;4(1):100211. doi: 10.1016/j.cellin.2024.100211. eCollection 2025 Feb.
4
RACK1 inhibits ferroptosis of cervical cancer by enhancing SLC7A11 core-fucosylation.RACK1 通过增强 SLC7A11 核心岩藻糖基化抑制宫颈癌中的铁死亡。
Glycoconj J. 2024 Oct;41(4-5):229-240. doi: 10.1007/s10719-024-10167-6. Epub 2024 Oct 2.
5
Three-Dimensional Structure of Novel Liver Cancer Biomarker Liver Cancer-Specific Serine Protease Inhibitor Kazal (LC-SPIK) and Its Performance in Clinical Diagnosis of Hepatocellular Carcinoma (HCC).新型肝癌生物标志物肝癌特异性丝氨酸蛋白酶抑制剂卡扎尔型(LC-SPIK)的三维结构及其在肝细胞癌(HCC)临床诊断中的性能
Diagnostics (Basel). 2024 Mar 29;14(7):725. doi: 10.3390/diagnostics14070725.
6
Recent Developments and Application of Mass Spectrometry Imaging in N-Glycosylation Studies: An Overview.质谱成像在N-糖基化研究中的最新进展与应用:综述
Mass Spectrom (Tokyo). 2024;13(1):A0142. doi: 10.5702/massspectrometry.A0142. Epub 2024 Feb 27.
7
Polyunsaturated Fatty Acid-Bound α-Fetoprotein Promotes Immune Suppression by Altering Human Dendritic Cell Metabolism.多不饱和脂肪酸结合型甲胎蛋白通过改变人树突状细胞代谢促进免疫抑制。
Cancer Res. 2023 May 2;83(9):1543-1557. doi: 10.1158/0008-5472.CAN-22-3551.
8
Targeted O-glycoproteomics for the development of diagnostic markers for advanced colorectal cancer.用于开发晚期结直肠癌诊断标志物的靶向O-糖蛋白质组学
Front Oncol. 2023 Feb 9;13:1104936. doi: 10.3389/fonc.2023.1104936. eCollection 2023.
9
Characterization of core fucosylation via sequential enzymatic treatments of intact glycopeptides and mass spectrometry analysis.通过对完整糖肽进行顺序酶处理和质谱分析来表征核心岩藻糖基化。
Nat Commun. 2022 Jul 7;13(1):3910. doi: 10.1038/s41467-022-31472-4.
10
Persistently Rising Alpha-fetoprotein in the Diagnosis of Hepatocellular Carcinoma: A Review.持续性升高的甲胎蛋白在肝细胞癌诊断中的应用:综述
J Clin Transl Hepatol. 2022 Feb 28;10(1):159-163. doi: 10.14218/JCTH.2021.00176. Epub 2021 Oct 18.